Upward intraday price spikes or sudden rallies for Ocugen, Inc. are usually catalyzed by positive corporate announcements, regulatory clearances from health authorities like the FDA regarding clinical trial advancements, or promising scientific data releases concerning its gene therapy portfolio. Positive news updates regarding Regenerative Medicine Advanced Therapy designations, successful capital funding announcements, or favorable analyst commentary can generate heightened retail and institutional buying interest, driving rapid upward momentum across active trading sessions.